
Combo flu-COVID vaccine shows good immune response, safety in older adults
Yesterday in JAMA, authors published promising results from a phase 3 trial on the safety and immunogenicity of a combined seasonal flu and COVID vaccine, Moderna's mRNA-1083, in adults 50 and older. The mRNA-1083 vaccine comprises components of mRNA- …